Quantum Art raises $100 million Series A to scale full-stack quantum systems
The Weizmann Institute spin-off aims to achieve commercial quantum advantage in just two years.
YZi Labs Invests in RenewalBio, another YEDA Spin-off, to Tackle Global Organ Shortages via Gene-Identical Regenerative Medicine
YZi Labs announced its investment in Renewal Bio, a next-generation regenerative medicine company using developmental biology to produce DNA-identical human cells and tissues from patient-derived pluripotent stem cells.
This marks YZi Labs’ first biotech investment since expanding its mandate in early 2025, reflecting the firm’s long-term commitment to backing technologies capable of healing at the deepest level and reshaping human health and longevity for generations to come.
CZ-Backed YZi Labs Enters Biotech With Investment in Renewal Bio
Cryptocurrencies are considered a high-risk asset class. Investing in them may result in the loss of part or all of your capital. The content on this website is intended solely for informational and educational use and should not be interpreted as financial or investment advice.
Immunai strikes $85M deal with AstraZeneca to develop new IBD drug target
AI biotech expands partnership after uncovering novel immune target with its machine learning platform.
Modulight Biotherapeutics Announces $12 Million Seed Funding for Novel Optogenetic Therapy to Treat Neurological Disorders
Modulight Biotherapeutics Announces $12 Million Seed Funding for Novel Optogenetic Therapy to Treat Neurological Disorders
The round was led by Jibe Ventures and LocalGlobe, with participation from Nexus NeuroTech Ventures, Redseed, Secret Chord Ventures, Fresh Fund, Saras Capital, Silverarc Capital, and Sha’ar Mivnim.
The funding marks a significant milestone for Modulight Biotherapeutics as they advance their mission to develop light-based therapeutics for the treatments of severe neurological diseases
Renewal Bio
RenewalBio aims to address the critical shortage of transplantable cells and organs by harnessing advanced stem cell technologies to generate authentic, transplant-ready human cells and tissues.
BIA Med
Bia Med is a Baby-Tech & Fem-Tech health startup developing innovative breast monitoring technology – a "Smart Bra" – that will provide women with personalized feedback on key physiological changes in their breasts.
Epivision
EPIVISION is a biotechnology company developing next-generation liquid biopsy solutions for early cancer detection and monitoring.
Chiral Energy
Controlling electron spin to significantly improve Batteries, Electrolyzers and Fuel cells
Pages
